All News

Takeda's Phase III Dengue Vaccine Results Bring Th

Takeda Pharmaceutical announced that its vaccine for dengue fever hit its primary efficacy endpoint
Read More

Celgene Strikes Deal Worth Nearly $1 Billion for B

Celgene has struck another collaborative deal, even as the large pharmaceutical company is in the pr
Read More

Gates Foundation, Gilead and Others Drop $55 Milli

Lyndra Therapeutics, based in Watertown, Mass., announced the closing of a Series B financing round
Read More

Is Biogen’s Aducanumab for Alzheimer’s the Holy Gr

Whenever a drug fails an Alzheimer’s clinical trial, analysts, investors and industry watchers immed
Read More

Senate Finance Committee and House Oversight Commi

In the Finance Committee hearing, chair of the committee, Sen. Chuck Grassley, (R-IA), began by sayi
Read More

Ready for Botox, millennials? Allergan has launche

Allergan’s latest target for Botox Cosmetic is millennials. If there's any doubt, just look at the c
Read More

Allergan abandons women’s health sale plan as prof

The Ireland-headquartered specialty drugmaker, best known for its Botox wrinkle treatment, reported
Read More


;